Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: bevacizumab|DRUG: letrozole
Sponsor: University of California, San Francisco
Collaborators: National Cancer Institute (NCI)|Memorial Sloan Kettering Cancer Center